Frias, J. P., Chien, J., Zhang, Q., Chigutsa, E., Landschulz, W., Wullenweber, P., . . . Kazda, C. (2021). Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin. J Endocr Soc.

Frias, Juan Pablo, Jenny Chien, Qianyi Zhang, Emmanuel Chigutsa, William Landschulz, Paula Wullenweber, Axel Haupt, a Christof Kazda. "Once Weekly Basal Insulin Fc (BIF) Is Safe and Efficacious in Patients With Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin." J Endocr Soc 2021.

Frias, Juan Pablo, et al. "Once Weekly Basal Insulin Fc (BIF) Is Safe and Efficacious in Patients With Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin." J Endocr Soc 2021.